Senators urge USPTO to curb ‘patent thicket’ abuse

A bipartisan group of six US senators have asked the US Patent and Trademark Office (USPTO) to address ‘patent thickets’, a tactic that pharmaceutical companies allegedly use to stifle competition.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

USPTO and FDA unite to tackle drug pricing

7 July 2022 The US Patent and Trademark Office and Food and Drug Administration have partnered to facilitate access to affordable drugs.

Americas

USPTO urges Vidal review of Arthrex petition

19 May 2022 The US Patent and Trademark Office has argued against a bid by medical device maker Arthrex, which wants recognition that an ex-interim acting director lacked the power to refuse to review its petition.

Americas

USPTO rules Broad owns CRISPR animal cell editing patents

1 March 2022 Patents core to the breakthrough gene-editing technology CRISPR belong to the University of Harvard and the Massachusetts Institute of Technology’s Broad Institute, the US Patent and Trademark Office has ruled.